TABLE 2

Aneurysm and Treatment Status of Members With KD

Clinical Characteristicn (%)
Aneurysm status
 None436 (79.9)
 Transient ectasia19 (3.5)
 Persistent ectasia3 (0.5)
 Transient aneurysm23 (4.2)
 Persistent aneurysm25 (4.6)
 Unknown40 (7.3)
Acute KD treatment
 IVIg + aspirin294 (53.8)
 IVIg + aspirin + antibiotics128 (23.4)
 Aspirin41 (7.5)
 IVIg9 (1.6)
 Other5 (0.9)
 None8 (1.5)
 Unknown61 (11.2)
Long-term KD treatment
 None430 (78.8)
 Aspirin52 (9.5)
 Aspirin + warfarin4 (0.7)
 Warfarin2 (0.4)
 Unknown58 (10.6)